MNDR Class A Mobile-health Network Solutions - Class A Ordinary Shares
NASDAQ · Health Care · View on SEC EDGAR ↗ 10-K/10-Q Apr 9, 2026
$0.87
· of 52w range
· above low
· to high
$0.7152w low
$32.5252w high
P/E
-8.4
EPS
$-3.82
Revenue
$8M
your badges
52W Range
$1–$33
Analyst Rating
BUY
Price Target
·
P/E
-8.4
ROE
-100.2%
Net Profit Margin
-44.2%
Your badge strip is empty — pin a metric anywhere on this page.
MNDR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.87
P/E
-8.4
EPS
$-3.82
Revenue
$8M
ROE
-100.2%
52W Range
$1–$33
MNDR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 29, 2026 | 1-for-6 | Reverse |
| June 22, 2026 | 1-for-6 | Reverse |
| Sept. 25, 2025 | 1-for-5 | Reverse |
| March 10, 2025 | 1-for-8 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$8M2022-06-30 → 2025-06-30
EPS$-3.822022-06-30 → 2025-06-30
Free Cash Flow$-4M2024-06-30 → 2025-06-30
Net margin-44.2%2024-06-30 → 2025-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MNDR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -8.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MNDR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 16.7% | · | · | · | |
| Pretax Margin | -44.2% | · | · | · | |
| Net Profit Margin | -44.2% | · | · | · | |
| ROA | -54.6% | · | · | · | |
| ROE | -100.2% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MNDR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | · | · | · | |
| Quick Ratio | 0.7 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MNDR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.2 | · | · | · | |
| Inventory Turnover | 47.5 | · | · | · | |
| Receivables Turnover | 69.5 | · | · | · | |
| Revenue / Employee | ≈$104.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Next Report
Oct 29, 2026
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $8M | $14M | $8M | $7M | |
| Cost of Revenue | $6M | $11M | $7M | $5M | |
| Gross Profit | $1M | $3M | $1M | $2M | |
| SG&A Expense | $3M | $5M | $2M | $615.5K | |
| Operating Expenses | $5M | $18M | $4M | $2M | |
| Other Non-op | $161.3K | $81.8K | $75.3K | $64.8K | |
| Pretax Income | $-3M | $-16M | $-3M | $258.5K | |
| Income Tax | · | $-19.2K | · | $165.8K | |
| Net Income | $-3M | $-16M | $-3M | $92.7K | |
| EPS (Basic) | $-3.82 | $-18.09 | $-5.04 | $0.01 | |
| EPS (Diluted) | $-3.82 | $-18.09 | $-5.04 | $0.01 | |
| Shares (Basic) | 885,796 | 862,293 | 637,050 | 21,600,500 | |
| Shares (Diluted) | 885,796 | 862,293 | 637,050 | 21,600,500 |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $7M | $2M | · | |
| Receivables | $109.0K | $111.1K | $74.3K | · | |
| Inventory | $103.9K | $164.0K | $146.4K | · | |
| Prepaid Expense | $105.4K | $108.2K | $38.8K | · | |
| Other Current Assets | $377.3K | $222.7K | $164.4K | · | |
| Current Assets | $2M | $7M | $3M | · | |
| PP&E (Net) | $138.4K | $216.0K | $178.8K | · | |
| PP&E (Gross) | $567.4K | $487.3K | $356.3K | · | |
| Accum. Depreciation | $429.0K | $271.2K | $177.5K | · | |
| Intangibles | $2M | $19.0K | $70.8K | · | |
| Other Non-current Assets | · | $56.0K | $82.0K | · | |
| Total Assets | $4M | $8M | $3M | $11M | |
| Accounts Payable | $870.8K | $2M | $1M | · | |
| Current Liabilities | $2M | $3M | $3M | · | |
| Capital Leases | · | $135.9K | $241.2K | · | |
| Total Liabilities | $2M | $4M | $4M | · | |
| Retained Earnings | $-28M | $-25M | $-9M | · | |
| AOCI | $591.2K | $428.2K | $289.0K | · | |
| Stockholders' Equity | $3M | $4M | $-367.2K | · | |
| Liabilities + Equity | $4M | $8M | $3M | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $172.0K | $149.1K | $94.8K | $87.1K | |
| Stock-based Comp | $414.1K | $9M | · | · | |
| Deferred Tax | · | · | · | $549 | |
| Amort. of Intangibles | $31.3K | $52.1K | $51.5K | · | |
| Operating Cash Flow | $-4M | $-6M | $-2M | $975.7K | |
| CapEx | $63.1K | $134.2K | $186.0K | $15.2K | |
| Investing Cash Flow | $-2M | $-134.2K | $-186.0K | $-15.2K | |
| Stock Issued | $984.1K | $11M | $843.1K | $10M | |
| Stock Repurchased | · | · | $7M | · | |
| Net Stock Activity | $984.1K | $11M | · | · | |
| Financing Cash Flow | $959.0K | $11M | $-6M | $9M | |
| Net Change in Cash | $-6M | $4M | $-8M | $10M | |
| Taxes Paid | · | · | $217.2K | · | |
| Free Cash Flow | $-4M | $-7M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 16.7% | 18.2% | · | · | |
| Net Margin | -44.2% | -111.7% | · | · | |
| Pretax Margin | -44.2% | -111.8% | · | · | |
| ROA | -54.6% | -273.9% | · | · | |
| ROE | -100.2% | -827.2% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 2.3 | · | · | |
| Quick Ratio | 0.7 | 2.2 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 2.5 | · | · | |
| Inventory Turnover | 47.5 | 73.7 | · | · | |
| Receivables Turnover | 69.5 | 150.7 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue / Share | $8.63 | $0.50 | · | · | |
| Cash Flow / Share | $-4.92 | $-0.23 | · | · | |
| EPS (TTM) | $-3.82 | $-18.09 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $8M | $14M | · | · | |
| Net Income TTM | $-3M | $-16M | · | · | |
| P/E | -8.4 | -18.7 | · | · | |
| Earnings Yield | -11.9% | -5.3% | · | · |
No quarterly filings for MNDR
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | $8M | $14M | $8M | $7M |
| Gross Margin % | 16.7% | 18.2% | · | · |
| Net Income | $-3M | $-16M | $-3M | $92.7K |
| Diluted EPS | $-3.82 | $-18.09 | $-5.04 | $0.01 |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Current Ratio | 1.1 | 2.3 | · | · |
| Quick Ratio | 0.7 | 2.2 | · | · |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | $-4M | $-7M | · | · |
Institutional owners (13F)
Institutional activity — Q1 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (-3 vs prior Q) | 2 (+1 vs prior Q) | 2 (+2 vs prior Q) | 0 (-2 vs prior Q) | -24K |
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Teoh Pui Pui ×2 filings | Jan. 20, 2026 | 4.00% | Amendment | · | SEC |
| Indopacific Health Investment Corporation Pte. Ltd. | Dec. 4, 2025 | 6.43% | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 3 insiders · 3 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Tung Yeng Siaw | Co-Chief Executive Officer | Aug. 27, 2026 A | 175,635 | 0 | 0 | $0 |
| Teoh Pui Pui | Co-Chief Executive Officer | Aug. 27, 2026 A | 163,621 | 0 | 0 | $0 |
| Aik Huat Leong | Chief Financial Officer | Aug. 27, 2026 A | 17,484 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
MNDR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F/A filed Apr 9, 2026